Valuation: Lifecare ASA

Market Cap 86.45M 8.79M 7.68M 7.05M 6.58M 12.47M 837M 12.68M 84.9M 32.9M 410M 33M 32.28M 1.41B P/E 2026 *
-0.76x
P/E 2027 * -1.04x
Enterprise Value 122M 12.45M 10.88M 9.99M 9.31M 17.66M 1.19B 17.96M 120M 46.6M 581M 46.74M 45.72M 2B EV / Sales 2026 *
-
EV / Sales 2027 * 24.9x
Free-Float
89.66%
Yield 2026 *
-
Yield 2027 * -
1 day+0.86%
1 week+0.86%
Current month+1.21%
1 month-2.50%
3 months-30.85%
6 months-70.75%
Current year-91.03%
1 week 0.28
Extreme 0.2815
0.32
1 month 0.27
Extreme 0.271
0.42
Current year 0.27
Extreme 0.27
2
1 year 0.27
Extreme 0.27
23.5
3 years 0.27
Extreme 0.27
82.16
5 years 0.27
Extreme 0.27
82.16
10 years 0.27
Extreme 0.27
117
Manager TitleAgeSince
Chief Executive Officer 50 2020-09-06
Director of Finance/CFO - 2026-03-31
Corporate Officer/Principal - 2024-02-29
Director TitleAgeSince
Director/Board Member - 2020-06-25
Chairman - 2021-05-07
Director/Board Member - 2020-11-19
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%+0.86%-94.78%-98.88% 8.79M
+0.18%+5.65%+1.44%+6.69% 49.15B
+0.92%+6.21%+408.85%+607.44% 40.23B
+1.89%+11.06%+25.75%-7.89% 34.55B
+2.38%+8.10%+21.83%+66.94% 33.09B
+1.20%+2.02%+9.79%+32.43% 25.19B
+2.51%+4.94% - - 17.05B
+2.58%+7.24%+71.03%+132.17% 15.92B
-0.06%+0.20%+13.24%+18.65% 13.83B
-1.14%+7.52%+14.75%-30.83% 13.26B
Average +1.13%+5.62%+52.43%+80.75% 24.23B
Weighted average by Cap. +1.19%+6.73%+88.29%+130.89%

Financials

2026 *2027 *
Net sales - 5M 508K 444K 408K 380K 721K 48.39M 733K 4.91M 1.9M 23.73M 1.91M 1.87M 81.78M
Net income -86M -8.74M -7.64M -7.01M -6.54M -12.4M -832M -12.61M -84.46M -32.73M -408M -32.82M -32.11M -1.41B -82M -8.34M -7.28M -6.69M -6.24M -11.82M -794M -12.02M -80.53M -31.21M -389M -31.3M -30.62M -1.34B
Net Debt 36M 3.66M 3.2M 2.94M 2.74M 5.19M 348M 5.28M 35.35M 13.7M 171M 13.74M 13.44M 589M 38M 3.86M 3.38M 3.1M 2.89M 5.48M 368M 5.57M 37.32M 14.46M 180M 14.5M 14.19M 621M
Logo Lifecare ASA
Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Employees
25
Date Price Change Volume
26-07-03 NOK 0.2925 +0.86% 394,817
26-07-02 NOK 0.2900 -0.51% 1,653,332
26-07-01 NOK 0.2915 +0.87% 2,901,547
26-06-30 NOK 0.2890 -0.34% 2,284,848
26-06-29 NOK 0.2900 0.00% 2,586,398

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIFE Stock